00:00 - Introduction to Lily and GLife’s vision for data-driven dermatology
01:20 - Lily’s scientific background
02:43 - Breakthroughs from single-cell atlases
03:50 - The motivation behind founding GLife
04:50 - The importance of treating skin as a foundational organ
05:48 - Discovery of key molecular drivers of aging
06:22 - Challenges of fundraising
07:45 - The novel approach to rejuvenating hair loss through targeted messenger RNA treatments
08:53 - How treatments will be delivered via microneedles and micro patches
09:32 - The potential to alter hair color and explore cosmetic applications
10:06 - Balancing platform discovery engines with the development of first-in-class therapeutics
10:43 - The comprehensiveness of the skin atlas and addressing genetic diversity
11:39 - Technical challenges of capturing skin’s cellular heterogeneity and stem cell populations
12:50 - The importance of isoforms and deep sequencing in understanding gene functions
13:16 - Short-lived messenger RNA as a safe, reversible treatment modality
14:55 - Safety considerations and toxicity management
16:01 - Biodistribution studies and local micro-needle delivery safety
17:00 - Next steps towards clinical trials and regenerative therapies for hair loss
18:08 - The role of big data and omics in understanding skin disorders and aging
19:04 - The significance of isoforms in skin biology and gene function
20:13 - Endogenous vs. modified messenger design for safety and efficacy
21:32 - Potential for multi-gene delivery to enhance hair regrowth and color restoration
22:22 - Conception of patches that work with existing hair without shaving
23:38 - Targeting broad hair loss types and the concept of root causes
24:47 - Modeling hair loss with animal models and regulatory considerations
25:48 - Regulatory perspectives on non-animal models and validation strategies
26:34 - The interplay between genetic and environmental causes of skin aging
27:54 - The biological hub role of specific transcription factors in stress and aging
29:10 - The future of skin biomarkers for diagnosis and personalized health monitoring
30:18 - Leveraging AI’s data integration and precision medicine in dermatology
32:32 - The impact of protein isoforms and post-translational modifications in skin treatment
34:47 - Interest in peptides, small molecules, and biohacking trends for skin health
36:03 - Collaboration between wet labs, computational teams, and clinical partners
36:36 - The significance of internal naming conventions in research and development
37:28 - The high-throughput screening process for key transcription factors
38:13 - Strategies for overexpressing target genes in therapeutic design
39:00 - AI’s role in accelerating discovery and development pipelines in biotech
40:39 - Addressing data quality, heterogeneity, and integration challenges in big datasets
44:12 - Envisioning personalized skincare driven by genomics and AI
44:56 - The inspiring concept that ancient technologies now seem like magic
45:24 - Challenges in bringing novel dermatological treatments through trials and regulation
47:42 - The evolving role of AI in drug quality control and documentation
48:11 - Unique advantages of Lily’s targeted mRNA approach over other modalities
49:22 - Using skin as a model system for broader human biology insights
50:28 - Perspectives on epigenetic reprogramming and cellular re-differentiation
51:22 - Fundraising experiences and strategic positioning for biotech development
52:21 - The influence of science fiction, especially “Three Body Problem” and “Interstellar,” on Lily’s vision
54:24 - Advice to young scientists: read widely, think deeply, and dream big
